Ephedrine as a lead compound for the development of new DPP-IV inhibitors.
Ojeda-Montes MJ, Ardid-Ruiz A, Tomás-Hernández S, Gimeno A, Cereto-Massagué A, Beltrán-Debón R, Mulero M, Garcia-Vallvé S, Pujadas G, Valls C.
Ojeda-Montes MJ, et al. Among authors: ardid ruiz a.
Future Med Chem. 2017 Dec;9(18):2129-2146. doi: 10.4155/fmc-2017-0080. Epub 2017 Nov 27.
Future Med Chem. 2017.
PMID: 29172693